Get started
SANTEN PHARMA.SANTEN PHARMA.SANTEN PHARMA.

SANTEN PHARMA.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

SZD chart


Full chart

SZD upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.28 B‬ EUR
Dividend yield (indicated)
2.20%
Price to earnings Ratio (TTM)
20.85
Basic EPS (TTM)
0.45 EUR
Net income (FY)
‪163.09 M‬ EUR
Revenue (FY)
‪1.85 B‬ EUR
Shares float
‪295.07 M‬
Beta (1Y)
0.37

Employees


Employees (FY)
‪3.74 K‬
Change (1Y)
−400 −9.65%
Revenue / Employee (1Y)
‪493.86 K‬ EUR
Net income / Employee (1Y)
‪43.56 K‬ EUR

About SANTEN PHARMACEUTICAL CO


Sector
Health Technology
CEO
Takeshi Ito
Headquarters
Osaka
Website
santen.co.jp
Founded
2016
ISIN
JP3336000009
FIGI
BBG000C2JZX7
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

SZD news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SZD is 9.35 EUR — it has decreased by −0.53% in the past 24 hours. Watch SANTEN PHARMA. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SANTEN PHARMA. stocks are traded under the ticker SZD.
SZD stock has fallen by −6.50% compared to the previous week, the month change is a −5.56% fall, over the last year SANTEN PHARMA. has showed a 7.47% increase.
We've gathered analysts' opinions on SANTEN PHARMA. future price: according to them, SZD price has a max estimate of 16.27 EUR and a min estimate of 10.64 EUR. Watch SZD chart and read a more detailed SANTEN PHARMA. stock forecast: see what analysts think of SANTEN PHARMA. and suggest that you do with its stocks.
SZD reached its all-time high on Jan 15, 2020 with the price of 18.10 EUR, and its all-time low was 1.60 EUR and was reached on May 27, 2003. View more price dynamics on SZD chart.
See other stocks reaching their highest and lowest prices.
SZD stock is 0.53% volatile and has beta coefficient of 0.37. Track SANTEN PHARMA. stock price on the chart and check out the list of the most volatile stocks — is SANTEN PHARMA. there?
Today SANTEN PHARMA. has the market capitalization of ‪3.14 B‬, it has decreased by −7.15% over the last week.
Yes, you can track SANTEN PHARMA. financials in yearly and quarterly reports right on TradingView.
SANTEN PHARMA. is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
SZD earnings for the last quarter are 0.15 EUR per share, whereas the estimation was 0.14 EUR resulting in a 7.37% surprise. The estimated earnings for the next quarter are 0.16 EUR per share. See more details about SANTEN PHARMA. earnings.
SANTEN PHARMA. revenue for the last quarter amounts to ‪447.59 M‬ EUR, despite the estimated figure of ‪466.27 M‬ EUR. In the next quarter, revenue is expected to reach ‪468.59 M‬ EUR.
SZD net income for the last quarter is ‪50.86 M‬ EUR, while the quarter before that showed ‪61.67 M‬ EUR of net income which accounts for −17.53% change. Track more SANTEN PHARMA. financial stats to get the full picture.
As of Dec 22, 2024, the company has ‪3.74 K‬ employees. See our rating of the largest employees — is SANTEN PHARMA. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SANTEN PHARMA. EBITDA is ‪436.12 M‬ EUR, and current EBITDA margin is 23.21%. See more stats in SANTEN PHARMA. financial statements.
Like other stocks, SZD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SANTEN PHARMA. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SANTEN PHARMA. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SANTEN PHARMA. stock shows the sell signal. See more of SANTEN PHARMA. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.